SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001347178-21-000022
Filing Date
2021-06-10
Accepted
2021-06-10 17:06:21
Documents
6
Effectiveness Date
2021-06-10

Document Format Files

Seq Description Document Type Size
1 S-8 vnda-20210610xs8.htm S-8 85739
2 EX-5.1 vnda-20210610sx8exhibit51.htm EX-5.1 9798
3 EX-10.1 vnda-s8exhibit101.htm EX-10.1 218440
4 EX-23.2 vndas-8pwcconsent.htm EX-23.2 2375
5 s8exhibit51image1a.jpg GRAPHIC 27579
6 s8exhibit51image2a.jpg GRAPHIC 66315
  Complete submission text file 0001347178-21-000022.txt   446894
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256994 | Film No.: 211008872
SIC: 2834 Pharmaceutical Preparations